These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 231294)

  • 1. Role of cyclic AMP in glucagon-induced stimulation of hepatic glucose output in man.
    Grill V; Cerasi E; Wahren J
    Scand J Clin Lab Invest; 1979 Dec; 39(8):689-96. PubMed ID: 231294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of insulin on splanchnic and peripheral glucose disposal after an intravenous glucose load in man.
    Saccà L; Cicala M; Trimarco B; Ungaro B; Vigorito C
    J Clin Invest; 1982 Jul; 70(1):117-26. PubMed ID: 6123524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient stimulatory effect of sustained hyperglucagonemia on splanchnic glucose production in normal and diabetic man.
    Bomboy JD; Lewis SB; Lacy WW; Sinclair-Smith BC; Liljenquist JE
    Diabetes; 1977 Mar; 26(3):177-4. PubMed ID: 190074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man.
    Felig P; Wahren J; Hendler R
    J Clin Invest; 1976 Sep; 58(3):761-5. PubMed ID: 956401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of glucagon on lipolysis and ketogenesis in normal and diabetic men.
    Liljenquist JE; Bomboy JD; Lewis SB; Sinclair-Smith BC; Felts PW; Lacy WW; Crofford OB; Liddle GW
    J Clin Invest; 1974 Jan; 53(1):190-7. PubMed ID: 4808635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of glucagon on net splanchnic cyclic AMP production in normal and diabetic men.
    Liljenquist JE; Bomboy JD; Lewis SB; Sinclair-Smith BC; Felts PW; Lacy WW; Crofford OB; Liddle GW
    J Clin Invest; 1974 Jan; 53(1):198-204. PubMed ID: 4357612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired responsiveness to the effect of glucagon on plasma adenosine 3':5'-cyclic monophosphate in normal man.
    Hendy GN; Tomlinson S; O'Riordan JL
    Eur J Clin Invest; 1977 Jun; 7(3):155-60. PubMed ID: 196859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of vasoactive intestinal polypeptide (VIP) on splanchnic and central hemodynamics in healthy subjects.
    Eriksson LS; Hagenfeldt L; Mutt V; Wahren J
    Peptides; 1989; 10(2):481-4. PubMed ID: 2666962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin synthesis inhibitors impair hepatic glucose production in response to glucagon and epinephrine stimulation.
    Miller JD; Ganguli S; Sperling MA
    Diabetes; 1983 May; 32(5):439-44. PubMed ID: 6301913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-glucagon interaction in controlling splanchnic glucose production in normal man.
    Bomboy JD; Lewis SB; Sinclair-Smith BC; Lacy WW; Liljenquist JE
    J Clin Endocrinol Metab; 1977 Mar; 44(3):474-80. PubMed ID: 838848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans.
    Wahren J; Efendić S; Luft R; Hagenfeldt L; Björkman O; Felig P
    J Clin Invest; 1977 Feb; 59(2):299-307. PubMed ID: 833277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output.
    Everett-Grueter C; Edgerton DS; Donahue EP; Vaughan S; Chu CA; Sindelar DK; Cherrington AD
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E449-59. PubMed ID: 16608886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responses of plasma adenosine 3',5'-monophosphate, blood glucose and plasma insulin to glucagon in humans.
    Søvik O; Heiervang E; Aksnes L; Selvig S
    Scand J Clin Lab Invest; 1981 Nov; 41(7):669-74. PubMed ID: 6280266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for an augmented glucagon dependence of hepatic glucose production in cirrhosis of the liver.
    Keller U; Sonnenberg GE; Burckhardt D; Perruchoud A
    J Clin Endocrinol Metab; 1982 May; 54(5):961-8. PubMed ID: 6120952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of epinephrine-induced glucose intolerance in normal humans.
    Saccà L; Vigorito C; Cicala M; Ungaro B; Sherwin RS
    J Clin Invest; 1982 Feb; 69(2):284-93. PubMed ID: 7035494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the kidney in the metabolism of fructose in 60-hour fasted humans.
    Björkman O; Felig P
    Diabetes; 1982 Jun; 31(6 Pt 1):516-20. PubMed ID: 6130022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.
    Orskov L; Alberti KG; Mengel A; Møller N; Pedersen O; Rasmussen O; Seefeldt T; Schmitz O
    Diabetologia; 1991 Jul; 34(7):521-6. PubMed ID: 1916058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitus.
    Wahren J; Felig P; Cerasi E; Luft R
    J Clin Invest; 1972 Jul; 51(7):1870-8. PubMed ID: 5032528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin sensitively controls the glucagon response to mild hypoglycemia in the dog.
    Igawa K; Mugavero M; Shiota M; Neal DW; Cherrington AD
    Diabetes; 2002 Oct; 51(10):3033-42. PubMed ID: 12351444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rapid changes of hepatic glycolytic enzymes and fructose-1,6-diphosphatase activities after intravenous glucagon in humans.
    Greene HL; Taunton OD; Stifel FB; Herman RH
    J Clin Invest; 1974 Jan; 53(1):44-51. PubMed ID: 4357616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.